TetraScience has added capacity for manufacturing and quality control data to its cloud-based software platform.
Boston-headquartered TetraScience announced the system expansion this week, citing the ability to monitor sensors and real-time devices like tablet presses, granulometers, drying units and handheld meters on the “shop floor” among the potential benefits.
A spokesman told Fierce CRO that, although manufacturing is the focus, the expansion lays the foundation for artificial-intelligence- and machine-learning-based drug discovery. The new tech can help provide cohesive data management across different phases of drug development and can assist in informing eventual regulatory submission.
The Tetra Scientific Data Cloud, which the firm claims is used by seven of the top 20 drug manufacturers worldwide, is intended to give access to data from every stage of the development lifecycle. According to TetraScience, connecting R&D, downstream manufacturing and QC data will yield breakthroughs in process development, analytical control, technology transfer and manufacturing risk reduction.
TetraScience has both CRO and CDMO clients, as well as biopharma customers that partner with networks of contract researchers. The technology is only offered under a subscription on the cloud as a platform as-a-service (PaaS) solution, according to the spokesperson.
The expansion is one of a number of moves TetraScience has made to bolster its capabilities since selling off a unit called Tetra Lab Monitoring, to data collection and reporting technology supplier Elemental Machines in December 2021. In June, TetraScience added Chemaxon, a web-based cheminformatics and bioinformatics software provider, to its partner network in a bid to help customers increase their capacity to find and synthesize chemical compounds.
Editor's note: This story was updated on July 20, 2022, at 10:40 a.m. ET to clarify that Elemental Machines acquired a unit of TetraScience called Tetra Lab Monitoring.